ArticlePediatric nephrology (Berlin, Germany)2007
Does rituximab treat recurrent focal segmental glomerulosclerosis post-renal transplantation?
Article in Pediatric nephrology (Berlin, Germany), 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases.Pediatric nephrology (Berlin, Germany) · 2008Trial
- Update on the treatment of focal segmental glomerulosclerosis in renal transplantation.World journal of transplantation · 2016Review
- Indications for use and safety of rituximab in childhood renal diseases.Pediatric nephrology (Berlin, Germany) · 2013Review
- Recent progress in the pathophysiology and treatment of FSGS recurrence.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2013Review
- Rituximab in post-transplant pediatric recurrent focal segmental glomerulosclerosis.Pediatric nephrology (Berlin, Germany) · 2013Article
- Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.Science translational medicine · 2011Article
- Treatment of recurrent focal segmental glomerulosclerosis in pediatric kidney transplant recipients: effect of rituximab.Journal of transplantation · 2011Article
- The factors that may predict response to rituximab therapy in recurrent focal segmental glomerulosclerosis: a systematic review.Journal of transplantation · 2011Article
- Rituximab in refractory nephrotic syndrome.Pediatric nephrology (Berlin, Germany) · 2010Article
- Disease recurrence in paediatric renal transplantation.Pediatric nephrology (Berlin, Germany) · 2009Review
- Rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosis.Clinical journal of the American Society of Nephrology : CJASN · 2009Article
- Nephrotic syndrome and rituximab: facts and perspectives.Pediatric nephrology (Berlin, Germany) · 2009Review
- Monoclonal antibodies for podocytopathies: rationale and clinical responses.Nature reviews. Nephrology · 2009Review
- Rituximab for plasma exchange-dependent recurrent focal segmental glomerulosclerosis after renal transplantation.NDT plus · 2008Article
- Rituximab: is replacement of cyclophosphamide and calcineurin inhibitors in steroid-dependent nephrotic syndrome possible?Pediatric nephrology (Berlin, Germany) · 2008Review
- Protracted remission of proteinuria after combined therapy with plasmapheresis and anti-CD20 antibodies/cyclophosphamide in a child with oligoclonal IgM and glomerulosclerosis.Pediatric nephrology (Berlin, Germany) · 2007Article
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
16937130What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.